These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25523028)

  • 1. Drug-, dose- and sex-dependent effects of chronic fluoxetine, reboxetine and venlafaxine on open-field behavior and spatial memory in rats.
    Gray VC; Hughes RN
    Behav Brain Res; 2015 Mar; 281():43-54. PubMed ID: 25523028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiolytic-like actions of reboxetine, venlafaxine and endurance swimming in stressed male rats.
    Lapmanee S; Charoenphandhu N; Krishnamra N; Charoenphandhu J
    Behav Brain Res; 2012 May; 231(1):20-8. PubMed ID: 22401815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of serotonin, noradrenaline and dopamine reuptake inhibitors on light-induced phase advances in hamster circadian activity rhythms.
    Gannon RL; Millan MJ
    Psychopharmacology (Berl); 2007 Dec; 195(3):325-32. PubMed ID: 17694388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
    Millan MJ; Dekeyne A; Papp M; La Rochelle CD; MacSweeny C; Peglion JL; Brocco M
    J Pharmacol Exp Ther; 2001 Aug; 298(2):581-91. PubMed ID: 11454919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does combined treatment with novel antidepressants and a dopamine D3 receptor agonist reproduce cocaine discrimination in rats?
    Filip M; Papla I
    Pol J Pharmacol; 2001; 53(6):577-85. PubMed ID: 11985331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid and monoamine systems mediate the discriminative stimulus of tramadol in rats.
    Filip M; Wydra K; Inan SY; Dziedzicka-Wasylewska M; Przegaliński E
    Eur J Pharmacol; 2004 Sep; 498(1-3):143-51. PubMed ID: 15363988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents.
    Brocco M; Dekeyne A; Veiga S; Girardon S; Millan MJ
    Pharmacol Biochem Behav; 2002 Apr; 71(4):667-80. PubMed ID: 11888558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotonergic and noradrenergic reuptake inhibition.
    Jones CK; Eastwood BJ; Need AB; Shannon HE
    Neuropharmacology; 2006 Dec; 51(7-8):1172-80. PubMed ID: 17045620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of fluoxetine, reboxetine, venlafaxine, and voluntary running exercise in stressed male rats with anxiety- and depression-like behaviors.
    Lapmanee S; Charoenphandhu J; Charoenphandhu N
    Behav Brain Res; 2013 Aug; 250():316-25. PubMed ID: 23707245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of fluoxetine and venlafaxine on memory recognition: possible mechanisms of action.
    Carlini VP; Poretti MB; Rask-Andersen M; Chavan RA; Ponzio MF; Sawant RS; de Barioglio SR; Schiöth HB; de Cuneo MF
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):159-67. PubMed ID: 22449479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of addition of yohimbine (alpha-2-receptor antagonist) to the antidepressant activity of fluoxetine or venlafaxine in the mouse forced swim test.
    Dhir A; Kulkarni SK
    Pharmacology; 2007; 80(4):239-43. PubMed ID: 17622775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressants that inhibit both serotonin and norepinephrine reuptake impair long-term potentiation in hippocampus.
    Cooke JD; Cavender HM; Lima HK; Grover LM
    Psychopharmacology (Berl); 2014 Dec; 231(23):4429-41. PubMed ID: 24781518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced signal transduction by 5-HT4 receptors after long-term venlafaxine treatment in rats.
    Vidal R; Valdizan EM; Vilaró MT; Pazos A; Castro E
    Br J Pharmacol; 2010 Oct; 161(3):695-706. PubMed ID: 20880406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celecoxib enhances the effect of reboxetine and fluoxetine on cortical noradrenaline and serotonin output in the rat.
    Johansson D; Falk A; Marcus MM; Svensson TH
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):143-8. PubMed ID: 22691715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of subchronic fluoxetine treatment on learning and memory in adolescent rats.
    Sass A; Wörtwein G
    Behav Brain Res; 2012 Mar; 228(1):169-75. PubMed ID: 22178317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant treatments change 5-HT2C receptor mRNA expression in rat prefrontal/frontal cortex and hippocampus.
    Barbon A; Orlandi C; La Via L; Caracciolo L; Tardito D; Musazzi L; Mallei A; Gennarelli M; Racagni G; Popoli M; Barlati S
    Neuropsychobiology; 2011; 63(3):160-8. PubMed ID: 21228608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
    Millan MJ; Gobert A; Lejeune F; Newman-Tancredi A; Rivet JM; Auclair A; Peglion JL
    J Pharmacol Exp Ther; 2001 Aug; 298(2):565-80. PubMed ID: 11454918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulus properties of venlafaxine in a conditioned taste aversion procedure.
    Kayir H; Alici T; Göktalay G; Yildirim M; Ulusoy GK; Ceyhan M; Celik T; Uzbay TI
    Eur J Pharmacol; 2008 Oct; 596(1-3):102-6. PubMed ID: 18786528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of antidepressant use on social functioning: reboxetine versus fluoxetine.
    Venditti LN; Arcelus A; Birnbaum H; Greenberg P; Barr CE; Rowland C; Williamson T
    Int Clin Psychopharmacol; 2000 Sep; 15(5):279-89. PubMed ID: 10993130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term administration of fluoxetine and venlafaxine decreases corticosteroid receptor mRNA expression in the rat hippocampus.
    Yau JL; Noble J; Hibberd C; Seckl JR
    Neurosci Lett; 2001 Jun; 306(3):161-4. PubMed ID: 11406320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.